{
  "id": 11856826,
  "title": "Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals",
  "url": "https://urgent.news/2026/10/04/better-state-street-healthcare-etf-xbis-biotech-focus-vs-xph-11856826",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-04T05:10:57.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/better-state-street-healthcare-etf-xbis-biotech-focus-vs-xph-targeting-pharmaceuticals"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsThe State Street SPDR S&P Biotech ETF and State Street SPDR S&P Pharmaceuticals ETF carry identical 0.35% expense ratios.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals",
        "url": "https://urgent.news/2026/10/04/better-state-street-healthcare-etf-xbis-biotech-focus-vs-xph",
        "published": "2026-10-04T04:50:57.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}